The U.S. recommendation to “pause” use of the single-dose Johnson & Johnson COVID-19 vaccine set off a chain reaction worldwide and dealt a setback to the global vaccine campaign. NBC New York's Ida Siegal reports.
About a quarter of a million people in New York City, including the mayor, have already received the J&J vaccine and about half a million residents statewide got the shot. None of them were among the six women who reported clotting problems.
Roughly 100,000 Connecticut residents have received the J&J vaccine with no reported serious adverse events either. Neither of the six women who suffered the clots were from New Jersey either, where J&J has accounted for more than 230,000 doses administered. That's about 4 percent of all doses done to date in the Garden State.